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1Heart disease remains a leading cause of death internation-ally,1 despite advances in the diagnosis and treatment of 
hypertension and cardiovascular disease (CVD). It has long 
been thought that the microvasculature may play a pivotal role 
in the pathogenesis of CVD.2 Optimal vascular architecture 
achieves the most efficient blood flow with minimum energy 
allowing for maximum vascular diffusion.3 Therefore, altera-
tions in geometry of the retinal vasculature may reflect a state 
of dysfunction of the microvasculature more generally and pro-
vide a noninvasive marker of lifetime CVD risk factor load2,4 
and potentially predict disease development.2,5
Retinal arteriolar narrowing has consistently been associ-
ated with higher blood pressure (BP)6–8 the onset of hyper-
tension5,9 and with an increased risk of incident CVD events 
and mortality.2 Evidence is emerging to suggest an association 
between tortuosity and an increased risk of stroke,4,8,10 and a 
growing body of evidence has suggested associations with ar-
terial stiffness, indicating systemic effects.11 To date, limited 
research has been undertaken to assess the association of ret-
inal vessel tortuosity with BP, and the direction of associations 
observed with vessel tortuosity have been inconsistent.4,6,12,13 
Previous smaller studies have shown an increase in vessel 
tortuosity (both arteriolar and venular tortuosity) with higher 
BP,8 while others have shown an association in the opposite 
direction or no association at all.4,6,12–14
With recent advances in technology, a study by Poplin et 
al15 using a deep learning approach has provided some en-
couraging evidence on the potential value of risk prediction 
utilizing retinal imaging at scale. While retinal vessels seem 
to be key areas of interest, understanding how these models 
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predict risk still remains a substantial problem of the deep 
learning approach. Retinal vessel morphometry assessment 
provides insight into the nature of vessel changes, further-
ing our understanding of potential mechanistic pathways. 
We examined the association of retinal vessel morphometry 
(using a fully automated retinal image analysis system)16 
with blood pressure (BP) and arterial stiffness in United 
Kingdom Biobank (UKBB).
Methods
Anonymized data will be made available by the UKBB on re-
quest https://www.ukbiobank.ac.uk/scientists-3/. UKBB recruited 
>500 000 people aged 40 to 69 years, between 2006 and 2010, from 
across the United Kingdom. A subset of 68 550 participants from 
6 UKBB centers had retinal images captured. The Cohort profile: 
design and methods in the eye and vision consortium of UKBB has 
recently been published.17 The eye and vision substudy has a very 
similar profile to the main UKBB study. Nonmydriatic fundus cam-
eras (Topcon 3D OCT-1000 Mk 2) with a 45° field-of-view were 
used to capture color images. Images were saved in PNG format 
with a resolution of 2048×1536 pixels.
Physical Examination
Age, sex, and other sociodemographic characteristics (at a post-
code level, neighborhood deprivation was expressed in terms of the 
the Townsend deprivation index, a higher Townsend index score 
implies a greater degree of deprivation) were collected by question-
naire. Height was measured to the nearest centimeter (cm) using a 
Seca 202 height measure, and a Tanita BC-418 body composition 
analyzer was used to measure weight to the nearest 0.1 kg. Body 
mass index (BMI) was calculated as weight (kilograms) divided by 
height squared (square meters). Two BP and heart rate measure-
ments were taken with an Omron 705 IT electronic BP monitor, 
while seated at least 1-minute apart18 and the average of the meas-
ures used in the analyses. A question on medication for BP was 
used to define antihypertensive medication usage. Hypertension 
was defined as having systolic BP≥140 mm Hg, or diastolic 
BP≥90 mm Hg, or self-reported use of antihypertensive medica-
tion. Mean arterial pressure (MAP) was calculated as [(2×diastolic 
BP)+systolic BP]/3. Mean pulse pressure (PP) was calculated as 
systolic BP minus diastolic BP. History of myocardial infarction, 
stroke, and diabetes mellitus were determined by self-report. The 
HbA1c assay was performed using 5 Bio-Rad Variant II Turbo 
analyzers. Analysis of serum biomarkers utilized 10 immuno-
assay analyzers (6× DiaSorin Liaison XL and 4× Beckman Coulter 
DXI 800 and 4 clinical chemistry analyzers (2× Beckman Coulter 
AU5800 and 2× Siemens Advia 1800).
Retinal Imaging and Processing
Retinal images were processed using an automated computerized 
system (QUARTZ [Quantitative Analysis of Retinal Vessel Topology 
and Size]).16 In brief, the automated system obtained thousands of 
measures of diameter and tortuosity from the whole retinal image.16,19,20 
These measures were summarized using mean diameter and tortuosity, 
weighted by vessel segment length, for arterioles and venules separately 
for each image. The following image processing modules were all vali-
dated on a subset of 4692 retinal images from a random sample of 2346 
UKBB participants: including vessel segmentation, image quality score, 
optic disc detection, vessel width measurement, tortuosity measurement, 
arteriolar venular recognition.16,20,21 The performance of the Arteriole/
Venule recognition had detection rates of up to 96% for arterioles and 
98% for venules when the automated probability of arteriole or venule 
was set to a cutoff of 0.8. An automated assessment of image quality was 
also made based on the segmented vasculature.21 The algorithm achieved 
a sensitivity of 95.3% and a specificity of 91.1% for the detection of in-
adequate images.20 A model eye was used to quantify the magnification 
characteristics of the Topcon 3D OCT-1000 Mk 2 fundus camera, allow-
ing pixel dimensions of vessel diameter to be converted to real size.22
Arterial Stiffness
Arterial stiffness was measured noninvasively using the pulse wave-
form obtained at the finger with an infra-red sensor (Pulse Trace 
PCA2, CareFusion).23 Participant’s height (meters) was divided 
by the time between the peaks of the pulse waveform to obtain the 
Arterial Stiffness Index (ASI) in meters per second.
The UKBB study was approved by the Northwest Region NHS 
research ethics committee.
Statistical Analysis
Stata 15.0 IC (Stata Corp LP, College Station, TX) was used to analyze 
the data. Retinal vessel diameters were normal distributed, measures 
of tortuosity were positively skewed, and therefore log-transformed. 
Multilevel linear regression models adjusting for age, sex, ethnicity, 
and UKBB center as fixed effects, with a random effect for person to 
allow for repeated measures of vessel indices within the same person 
(model 1), were used to examine associations of cardiometabolic 
risk factors with retinal vessel outcomes. Model 2 extended model 
1 with further adjustment for smoking, Townsend deprivation index, 
and BMI. Model 3 included the same factors as model 2 with addi-
tional adjustment for total cholesterol, triglycerides, and HbA1c and 
exclusion participants with a history of myocardial infarction, stroke, 
diabetes mellitus, on treatment for hypertension or who answered un-
known or declined to answer. Data missing on categorical variables 
were included as an additional category for each variable, to mini-
mize data loss. Associations with the log-transformed tortuosity were 
exponentiated to give percentage differences in tortuosity and abso-
lute differences (in microns) in vessel width per specified increase 
with CVD risk markers. Associations between retinal markers and 
each CVD risk factor were examined for interactions with sex; inter-
actions were considered statistically significant if the P for interaction 
were <0.01 given the large sample size of UKBB.
Results
A total of 54 714 participants (79.8% of UKBB participants 
who underwent fundus imaging) were included in these 
analyses (Figure 1). Population characteristics are shown in 
Table 1. Figure 2 shows adjusted mean retinal vessel measures 
(adjusted for age, sex, and random effect for person), by risk 
factor deciles.
Retinal Tortuosity, BP, and ASI Measures
Increased arteriolar tortuosity was associated with higher 
systolic BP, diastolic BP, MAP and PP, after adjustment 
(Table 2, model 1). For example, a 10 mmHg higher sys-
tolic BP was associated with a 1.2% (95% CI, 0.9; 1.4%; 
P=6.4×10−20) rise in arteriolar tortuosity. Associations 
observed were unaffected by additional adjustments in 
model 2 or after removal of participants with history of 
CVD and with adjustment for total cholesterol, triglycer-
ides, and HbA1c (model 3—Table S1 in the online-only 
Data Supplement). Increased retinal venular tortuosity was 
associated with higher systolic BP, diastolic BP, MAP, PP, 
and ASI (model 1). For example, a 10 mmHg rise in PP 
was associated with a 1.1% (0.8%–1.3%) rise in venular 
tortuosity. Adjustment for factors in model 2 marginally 
attenuated the association of venular tortuosity with sys-
tolic BP and PP, but each association remained highly 
statistically significant. However, associations were no 
longer significant for MAP or ASI. Removal of partici-
pants with history of CVD (model 3, Table S1) and adjust-
ment for total cholesterol, triglycerides, and hbA1c did not 
alter these associations but the association with diastolic 
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of increased tortuosity (both arteriolar and venular tortu-
osity) with higher systolic BP remained after adjustment 
for retinal diameters.
Retinal Diameters BP and ASI Measures
Narrower arterioles were associated with higher systolic BP, 
diastolic BP, MAP, PP, heart rate, and ASI (Table 3, model 
1). For example, a unit increase in ASI was associated with 
a −0.11 µm (−0.13, −0.09 µm; P=8.59×10−23) decrease in ar-
teriolar diameter, which would equate approximately to 0.33 
µm narrowing per SD increase in ASI. Adjustments in model 
2 had no impact on the association of narrower arterioles with 
higher systolic BP, diastolic BP, MAP, PP, heart rate, and ASI. 
Additional adjustment for systolic BP had little impact on the 
association of ASI with arteriolar diameter. The associations 
with CVD risk factors were unaffected by removal of those 
with history of CVD or adjustment for total cholesterol, tri-
glycerides, and HbA1c (model 3, Table S2). Narrower venules 
were also associated with higher systolic BP, diastolic BP, 
MAP, and PP. Wider venules were associated with increased 
ASI and heart rate (model 1, Table 3). Adjustment for addi-
tional confounding (model 2) did not alter the associations 
(with diameters), except for ASI which was no longer signif-
icantly associated with wider venules. Associations were un-
affected by removal of event history or adjustment for total 
cholesterol, triglycerides, and HbA1c (model 3; Table S2).
Although females exhibited narrower and more tortuous ves-
sels, formal tests of interaction of all associations with sex were not 
statistically significant. Out of 36 tests for interaction performed, 
6 were statistically significant at the 1% level. However, the abso-
lute differences in slopes were minimal, and all of the associations 
were in the same direction in men and women (data available on 
request). None of the associations were in opposing directions and 
the results are presented for men and women combined.
Discussion
In this study, the first to examine the retinal microvasculature 
at scale using fully automated software (with over 3.5 million 
vessel segments from over 50 000 participants), we have shown 
novel associations between retinal microvascular tortuosity with 
BP and ASI and confirmatory associations with diameters. Each 
significant risk factor expressed in deciles (Figure 2) showed 
strong graded associations with retinal vessel morphometry 
measures. The associations held after adjustment for confound-
ing factors and removal of those with self-reported diabetes 
mellitus and CVD morbidity. Importantly these morphometric 
associations may be indicative of preclinical disease processes, 
suggesting a role in CVD risk prediction.
Retinal Tortuosity and CVD Risk Factors
The key findings from the present study were that increased 
retinal tortuosity (arteriolar and venular) showed strong 
Figure 1. Flow of participants by exclusion 
from the United Kingdom Biobank retinal 
imaging study. QUARTZ indicates Quantitative 
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graded associations with higher BP, MAP, and PP, with P as 
small as 1×10−300. The retinal microvasculature abnormali-
ties observed with increased BP have not been so clear until 
now (Figure 2). The European Prospective Investigation 
into Cancer-Norfolk Eye study of 5947 participants (which 
used an identical methodology) showed remarkably similar 
increased tortuosity with systolic BP in older adults (arte-
riolar tortuosity, 1.2%; 95% CI, 0.5; 1.9% per 10 mmHg 
and venular tortuosity, 0.5%; 95% CI, 0.02; 0.88% per 10 
mmHg).8 However, evidence from other smaller scale stud-
ies have been less supportive. A nested case-control study 
by Witt et al4 among 682 adults showed an increase in ar-
teriolar tortuosity was weakly associated with higher sys-
tolic BP, with no evidence of an association with venular 
tortuosity. In contrast, a cross-sectional study by Cheung et 
al14 showed a decrease in arteriolar tortuosity with higher BP 
and MAP and an increase in venular tortuosity with higher 
BP and MAP, in an Asian population of adults (n=2915). 
Disagreements between studies may be because of smaller 
sample sizes together with measurement error (particularly 
with methods relying on manual measurement), where there 
is less certainty over the presence or absence of underlying 
associations.
While tortuosity (arteriolar and venular) was higher overall 
among women compared with men, in the present study, the 
association between CVD risk markers and tortuosity was ev-
ident in both sexes (and independent of further adjustment for 
height). Overall, the association of increased tortuosity (both 
arteriolar and venular tortuosity) with higher BP in the pre-
sent study was independent of retinal diameters. This suggests 
that tortuosity reflects different structural vascular changes 
from those shown for diameters and may provide additional 
value to CVD risk prediction tools beyond the current testing 
of diameters.24
The association of retinal tortuosity with stroke has 
not been well studied, although 2 studies have shown a 
more tortuous retinal microvascular network with prev-
alent stroke.8,10 In UKBB, there was no evidence of an 
association between self-reported stroke and arteriolar 
tortuosity. This difference may be related to differences in 
age (UKBB participants are relatively younger) and case 
ascertainment of stroke. In UKBB, presence of stroke 
was based on self-report, while in the other studies it 
was based on clinical information from health records.8,10 
Conversely, in the present study, increased venular tortu-
osity was strongly associated with stroke for which some 
Table 1. Characteristics of the Population by Inclusion and Exclusion Criteria
Characteristics Total Included Excluded
N 68 535 54 714 13 821
Age, y 56.8 (8.1) 56.1 (8.2) 59.3 (7.5)
Sex (% female) 54 55 50
Ethnicity (%)
  White 89.9 90.9 86.0
  Black 3.2 2.9 4.7
  Asian 3.2 2.8 4.8
  Other 2.9 2.8 3.5
  Unknown/missing 0.7 0.7 1.0
Smoking (%)
  Never smoker 55.2 55.9 52.2
  Occasionally 2.9 2.9 2.7
  Ex-smoker 34.5 33.9 36.9
  Current smoker 6.8 6.7 7.3
  Prefer not to say/
missing
0.7 0.6 0.9
Quartiles of Townsend deprivation index (%)
  <−3.4 25.0 25.1 24.5
  −3.4 to −1.6 25.0 25.3 23.8
  −1.7–0.8 25.0 25.0 24.7
  >0.8 25.0 24.5 26.9
  Missing 0.1 0.1 0.1
Salt intake (%)
  Never salt 56.2 56.6 54.6
  Sometimes salt 27.8 27.6 28.5
  Usually salt 11.2 11.1 11.7
  Always salt 4.5 4.4 4.8
  Prefer not to say/
missing
0.3 0.3 0.5
Medication for BP (%) 9.9 9.4 12.0
Systolic BP (mm Hg) 137.1 (18.4) 136.5 (18.3) 139.6 (18.7)
Diastolic BP (mm Hg) 81.8 (10.0) 81.7 (10.0) 82.1 (10.1)
Mean arterial pressure 
(mm Hg)
100.2 (11.8) 100.0 (11.8) 101.2 (11.8)
Mean pulse pressure 
(mm Hg)
55.4 (13.5) 54.8 (13.3) 57.5 (14.2)
Heart rate (bpm) 68.3 (11.1) 68.3 (11.0) 68.5 (11.3)
Pulse wave ASI (m/s) 9.4 (3.0) 9.4 (2.9) 9.7 (3.0)
BMI (kg/m2) 27.4 (4.8) 27.3 (4.7) 27.8 (4.9)
Arteriolar width (µm) * 88.0 (7.8) *
Venular width (µm) * 103.9 (13.1) *
Arteriolar tortuosity * 4.4 (1.6) *
Venular tortuosity * 3.2 (1.4) *
(Continued )
Image quality * 0.9 (0.1) *
History of heart attack (%) 2.0 1.8 2.8
History of stroke (%) 1.2 1.1 1.4
Diabetes mellitus (%) 5.6 4.9 8.2
Mean (SD) or %. Data missing on categorical variables have been included 
as an additional category for each variable, to minimize data loss. ASI indicates 
arterial stiffness index; BMI, body mass index; and BP, blood pressure.
*Data only on those included in the study available. Data were missing on the 
following continuous variable: pulse wave ASI (n=523).
Table 1. Continued
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evidence has been reported previously.8,10 The discrepan-
cies overall in findings from earlier studies with tortuosity 
may relate to the limited sample sizes, characteristics of 
the population (ie, age and risk factor profile, differences 
in diabetes mellitus duration, and type) or the time place-
ment of the study. For example, treatment has improved 
over time and therefore it may be harder to observe 
changes associated with a history of events in more recent 
studies compared with studies from 10 to 20 years ago. 
Given the strong graded association of CVD risk factors 
with tortuosity (both arteriolar and venular) in the present 
study of over 50 000 participants and the replication of the 
findings observed in EPIC,8 the associations between tor-
tuosity and CVD risk factors are now very clear warrant-
ing verification in a large longitudinal follow-up study, to 
confirm causality.
Retinal Diameters and CVD Risk Factors
Retinal arteriolar narrowing has consistently been associ-
ated with elevated BP in epidemiological studies6–8,25 and 
Figure 2. Adjusted mean retinal vessel width and tortuosity by deciles of cardiovascular disease (CVD) risk factors. Adjusted means (solid square symbols), 
95% CIs (solid vertical error bars) and regression line (dotted line) are from a multilevel model allowing for age, sex, and CVD risk maker decile as fixed 
effects and repeated retinal vessel measures within each person. BP indicates blood pressure.
Table 2. Percentage Differences in Arteriolar and Venular Tortuosity Associated With CVD Risk Factors
Risk Marker
Percentage Difference in Arteriolar Tortuosity (95% CI) Percentage Difference in Venular Tortuosity (95% CI)
Model 1 Model 2 Model 1 Model 2
 P Value  P Value  P Value  P Value
Age per decade 2.39 (1.87–2.92) 1.1×10−19 2.45 (1.93–2.99) 4.7×10−20 2.46 (2.14–2.77) <1.0×10−300 2.41 (2.09–2.73) <1.0×10−300
Sex (female) 4.23 (3.37–5.10) 1.3×10−22 4.40 (3.52–5.27) 8.5×10−24 1.37 (0.87–1.88) 8.0×10−08 1.83 (1.32–2.34) 1.5×10−12
SBP per 10 mmHg 1.15 (0.90–1.39) 6.4×10−20 1.18 (0.93–1.43) 2.2×10−20 0.63 (0.48–0.77) 7.3×10−17 0.42 (0.27–0.57) 4.0×10−08
DBP per 10 mmHg 0.76 (0.34–1.19) 3.9×10−04 0.79 (0.35–1.23) 3.9×10−04 0.30 (0.05–0.55) 0.019 −0.32 (−0.58 to −0.06) 0.016
MAP per 10 mm Hg 1.24 (0.87–1.61) 4.1×10−11 1.30 (0.92–1.68) 1.9×10−11 0.62 (0.40–0.84) 3.6×10−08 0.16 (−0.07–0.38) 0.166
MPP per 10 mm Hg 1.78 (1.43–2.13) 1.4×10−23 1.80 (1.44–2.15) 6.9×10−24 1.05 (0.84–1.26) 4.9×10−23 1.02 (0.81–1.23) 9.2×10−22
HR per 10 bpm −0.35 (−0.73–0.02) 0.065 −0.43 (−0.81 to −0.04) 0.030 −0.19 (−0.42–0.04) 0.098 −0.60 (−0.83 to −0.37) 2.6×10−07
PW ASI per m/s 0.12 (−0.03–0.27) 0.111 0.10 (−0.05–0.25) 0.203 0.11 (0.03–0.20) 0.012 0.02 (−0.07–0.11) 0.633
Percentage differences in retinal vessel tortuosity are from a multilevel model allowing for repeated images from the same person (random effect for person). Model 1 
adjusting each factor for age, sex, ethnicity, and United Kingdom Biobank center as fixed effects (n=54 714). Model 2 adjusting each factor for model 1 plus body mass 
index, smoking, and the Townsend deprivation index, as fixed effects (n=54 714). Note, a P Value of <0.00001 would be 1.0×10−5, hence 1.0×10−300 is an extremely 
small probability. CVD indicates cardiovascular disease; DBP, diastolic BP; HR, heart rate; MAP, mean arterial pressure; MPP, mean pulse pressure; PW ASI, pulse wave 
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meta-analysis,9 supporting the finding of the present study 
(Figure 2), where each 10 mmHg increase in systolic BP 
was associated with a 0.9 µm narrowing in arteriolar diam-
eter. The weaker association observed for venular diameter in 
the present study and no association observed in smaller pre-
vious studies6,7 suggests that the impact of BP on arterioles is 
more prominent than on venules. In general, the literature is in 
agreement that arterioles and venules are differentially associ-
ated with cardiometabolic risk factors; narrower arterioles are 
associated with higher BP8, and wider venules with inflamma-
tion and higher BMI/obesity.8,26 This most likely relates to the 
effect of different mechanistic pathways, which are yet to be 
fully understood.
We identified a strong association between older age and 
venular widening (Figure 2) and arteriolar narrowing. The 
aging process has been linked to decreased retinal vessel den-
sity, reduced inner retinal layer thickness, and retinal blood 
flow velocity, particularly in venules.27 The sex difference, 
with females having narrower arteriolar and venular diameters 
compared with males would need to be considered in the de-
velopment of CVD risk prediction tools.
Future Direction—Fully Automated CVD Risk 
Prediction
The work by Poplin et al15 using a convolutional neural net-
work was able to predict CVD risk factors and outcomes 
from a retinal image alone as accurately as available CVD 
risk prediction tools. In support of growing evidence, the 
present study has shown that narrower arteriolar diame-
ters are associated with increased BP, ASI, and PP very 
strongly and provide an indication of systemic microvas-
cular and macrovascular changes.11 Understanding how 
models predict risk remains a substantial problem of the 
deep learning, which is very much a black box approach; 
therefore, assessment of vessel morphology coupled with 
convolutional neural network deep learning approaches 
may help further inform potential pathways of disease pro-
cesses and prediction.
The strength of this study includes its large sample size 
of over 50 000 participants. The QUARTZ software is fully 
automated, incorporates convolutional neural network tech-
nology, and utilizes information from all vessels extracted 
within an image, providing precise measurement. A poten-
tial limitation is the use of the entire retinal image compared 
with a section of the image used by other grading systems; 
however, given our findings are consistent with previous lit-
erature, this is unlikely to be a major issue. The study lim-
itations include the cross-sectional study design, meaning 
the issue of causality cannot be resolved until further fol-
low-up. Although the UKBB is not a representative sample 
of the United Kingdom population, which is an issue if one 
were attempting to determine prevalence of outcomes or ge-
netic associations in particular.28 However, this study was fo-
cused on assessing cross-sectional phenotypic associations, 
and Pizzi et al29 showed that using restricted sampling for 
a cohort study is unlikely to appreciably bias estimates of 
exposure-disease associations, under a range of potential 
scenarios. In support of this, our findings show very sim-
ilar patterns of association to those observed in an entirely 
independent United Kingdom-based cohort study of similar 
Table 3. Mean Difference in Arteriolar and Venular Diameter (micrometers) Associated With CVD Risk Factors
 
Risk Marker
Absolute Difference in Arteriolar Diameter (95% CI) in µm Absolute Difference in Venular Diameter (95% CI) in µm
Model 1 Model 2 Model 1 Model 2
 P Value  P Value  P Value  P Value
Age per decade −0.56  
(−0.63 to −0.48)
<1.0×10−300 −0.51  
(−0.59 to −0.43)
<1.0×10−300 1.00  
(0.87–1.13)
<1.0×10−300 1.02  
(0.89–1.16)
<1.0×10−300
Sex (female) −0.18  
(−0.31 to −0.05)
5.1×10−03 −0.18  
(−0.31 to −0.05)
5.5×10−03 −0.72  
(−0.93 to −0.50)
7.1×10−11 −0.53  
(−0.74 to −0.31)
1.90×10−06
SBP per 10 mmHg −0.91  
(−0.94 to −0.87)
<1.0×10−300 −0.90  
(−0.94 to −0.87)
<1.0×10−300 −0.25  
(−0.32 to −0.19)
5.8×10−15 −0.31  
(−0.37 to −0.25)
2.29×10−21
DBP per 10 mmHg −1.62  
(−1.68 to −1.55)
<1.0×10−300 −1.66  
(−1.72 to −1.59)
<1.0×10−300 −0.30  
(−0.41 to −0.19)
7.7×10−08 −0.47  
(−0.58 to −0.36)
2.08×10−16
MAP per 10 mm Hg −1.49  
(−1.54 to −1.43)
<1.0×10−300 −1.51  
(−1.57 to −1.46)
<1.0×10−300 −0.34  
(−0.43 to −0.24)
2.6×10−12 −0.47  
(−0.57 to −0.37)
1.66×10−21
MPP per 10 mm Hg −0.72  
(−0.77 to −0.67)
<1.0×10−300 −0.71  
(−0.76 to −0.66)
<1.0×10−300 −0.30  
(−0.39 to −0.21)
3.6×10−11 −0.31  
(−0.39 to −0.22)
2.1×10−11
HR per 10 bpm −0.14  
(−0.20 to −0.08)
1.9×10−06 −0.13  
(−0.19 to −0.07)
1.6×10−05 0.59  
(0.50–0.69)
6.4×10−33 0.47  
(0.37–0.57)
1.2×10−20
PW ASI per m/s −0.11  
(−0.13 to −0.09)
8.6×10−23 −0.12  
(−0.14 to −0.09)
2.9×10−24 0.08  
(0.04–0.11)
1.2×10−04 0.03  
(−0.01–0.07)
0.090
Absolute difference in retinal vessel diameter are from a multilevel model allowing for repeated images from the same person (random effect for person). Model 1 
adjusting each factor for age, sex, ethnicity, and United Kingdom Biobank center as fixed effects (n=54 714). Model 2 adjusting each factor for model 1 plus body mass 
index, smoking, and the Townsend deprivation index, as fixed effects (n=54 714). Note a P Value of <0.00001 would be 1.0×10−5, hence 1.0×10−300 is an extremely 
small probability. CVD indicates cardiovascular disease; DBP, diastolic BP; HR, heart rate; MAP, mean arterial pressure; MPP, mean pulse pressure; PW ASI, pulse wave 
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and older age (the EPIC-Norfolk study).8 The impact of hy-
pertension treatment duration could not be assessed, so we 
are unsure of the impact of treatment duration on the as-
sociation between retinal measures and BP, though we did 
note that removing those on BP treatment did not alter the 
associations observed. The PWV device used a nonrefer-
ence method to estimate PWV, which is not as accurate as 
other approaches and may have led to an underestimation of 
the association, particularly given that pulse pressure shows 
stronger associations than PWV in this study. However, re-
assuringly, the association is in the expected direction and a 
P of 2.9×10−24 is highly unlikely to be a chance finding. This 
lends weight to the null association observed between PWV 
and vessel tortuosity
Perspectives
This study assessing the retinal microvasculature at scale has 
shown clear associations between retinal vessel morphometry, 
BP, and ASI. These observations further our understanding of 
the preclinical disease processes and interplay between micro-
vascular and macrovascular disease.
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What Is New
•	This is the first study to examine the retinal microvasculature at scale 
using fully automated software (with over 3.5 million vessel segments 
from over 50 000 participants), taking retinal morphology assessment 
from just a research tool to having potential use within clinical practice.
•	The observations from this study further our understanding of the pre-
clinical disease processes, and relationship between microvascular and 
macrovascular changes.
What Is Relevant?
•	There are clear linear associations between retinal vessel morphometry 
measures and blood pressure and arterial stiffness index.
•	Associations held after adjustment for confounding factors and removal 
of those with self-reported diabetes mellitus and cardiovascular disease 
morbidity.
Summary
•	This study assessing the retinal microvasculature at scale has shown 
clear associations between retinal vessel morphometry, blood pressure, 
and arterial stiffness index.
•	 Importantly, these morphometric associations may be indicative of pre-
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